Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: Long-term follow-up

Thyroid

Volumn 22, Issue 4, 2012, Pages 369-376

  Barbesino, Giuseppe ^a   Goldfarb, Melanie ^b   Parangi, Sareh ^a,c   Yang, Jingyun ^d   Ross, Douglas S ^a   Daniels, Gilbert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROTROPIN;

ARTICLE; CANCER PATIENT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EVALUATION AND FOLLOW UP; FEMALE; FOLLICULAR CARCINOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOACTIVE IODINE LOBE ABLATION; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; TUMOR ABLATION;

ADULT; AGED; CARCINOMA, PAPILLARY, FOLLICULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TREATMENT OUTCOME;

EID: 84859300841     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0198     Document Type: Article

References (30)

1. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425-437. (Pubitemid 351829800)
2. Baloch Z, Li Volsi VA 2002 Pathology of the thyroid gland. In Li Volsi VA, Asa SL (eds) Endocrine Pathology. Churchill Livingstone, New York, pp 61-88.
3. Thompson LDR 2006 Malignant neoplasms of the thyroid gland. In Thompson LDR (ed) Endocrine Pathology. Churchill Livingstone Elsevier, Philadelphia, PA, pp 61-88.
4. D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH 2004 Follicular thyroid carcinoma: histology and prognosis. Cancer 100:1123-1129. (Pubitemid 38325938)
5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
6. Randolph GW, Daniels GH 2002 Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid. 12:989-996. (Pubitemid 35404133)
7. Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Quan-Yang D, Hormoz E, Farrar W, Haddad RI, Hunt JP, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, Mccaffrey J, Moley JF, Olson JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ 2010 NCCN Clinical Practice Guidelines in Oncology Thyroid Carcinoma. NCCN. www.nccn.org
8. van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, Grant CS 1992 Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy. Surgery 112:1130-1136; discussion 1136-1138.
9. De Carlucci D, Jr., Tavares MR, Obara MT, Martins LA, Hojaij FC, Cernea CR 2008 Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism. Arch Otolaryngol Head Neck Surg 134:1076-1079.
10. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91:926-932. (Pubitemid 43357760)
11. Fast S, Nielsen VE, Bonnema SJ, Hegedus L 2009 Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function comparison of 0.1, 0.3 and 9mg of rhTSH. Clin Endocrinol (Oxf) 72:411-416.
12. Calabro S, Auguste LJ, Attie JN 1988 Morbidity of completion thyroidectomy for initially misdiagnosed thyroid carcinoma. Head Neck Surg 10:235-238. (Pubitemid 19088895)
13. Cambil T, Gil E, Ponce C, Ruiz JV, Castro J 2003 [Bilateral vocal cords paresis following iodine therapy]. Rev Esp Med Nucl 22:97-99. (Pubitemid 47226377)
14. Lee TC, Harbert JC, Dejter SW, Mariner DR, VanDam J 1985 Vocal cord paralysis following I-131 ablation of a postthyroidectomy remnant. J Nucl Med 26:49-50. (Pubitemid 15161423)
15. Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L, Farag A, Zanation AM 2008 Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Arch Otolaryngol Head Neck Surg 134:581-586. (Pubitemid 351871015)
16. Arad E, O'Mara RE, Wilson GA 1993 Ablation of remaining functioning thyroid lobe with radioiodine after hemithyroidectomy for carcinoma. Clin Nucl Med 18:662-663. (Pubitemid 23229598)
17. Bal CS, Kumar A, Pant GS 2003 Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer. Nucl Med Commun 24:203-208.
18. Hoyes KP, Owens SE, Millns MM, Allan E 2004 Differentiated thyroid cancer: radioiodine following lobectomy-a clinical feasibility study. Nucl Med Commun 25:245-251. (Pubitemid 38393515)
19. Santra A, Bal S, Mahargan S, Bal C 2011 Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer. Nucl Med Commun 32:52-58.
20. Leblanc G, Tabah R, Liberman M, Sampalis J, Younan R, How J 2004 Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of welldifferentiated thyroid cancer. Surgery 136:1275-1280. (Pubitemid 39647545)
21. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM 1991 Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66:11-22.
22. Alzahrani AS, Mohamed G, Al Shammary A, Aldasouqi S, Abdal Salam S, Shoukri M 2005 Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer. J Endocrinol Invest 28:540-546. (Pubitemid 43162888)
23. Chao M 2010 Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan. Clin Oncol (R Coll Radiol) 22:438-447.
24. Pacini F, Agate L, Elisei R, Capezzone M, Ceccarelli C, Lippi F, Molinaro E, Pinchera A 2001 Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-4097. (Pubitemid 32848518)
25. Kloos RT 2008 Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer. J Clin Endocrinol Metab 93:1519-1525. (Pubitemid 351656484)
26. Shaha AR, Shah JP, Loree TR 1996 Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172: 692-694. (Pubitemid 27024782)
27. Allan E, Owens SE, Waller ML 1999 Differentiated thyroid cancer lobectomy and radioiodine, a treatment suitable for all cases? Nucl Med Commun 20:983-989. (Pubitemid 29534147)
28. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O 2008 TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: A 5-year prospective randomized study. Eur J Endocrinol 158:69-75. (Pubitemid 351211042)
29. Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS 2001A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91:505-524. (Pubitemid 32105696)
30. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA 2006 Follicular variant of papillary thyroid carcinoma: A clinicopathologic study of a problematic entity. Cancer 107:1255-1264. (Pubitemid 44452774)